Peptide Depots
Peptide Depots is a type of injectable depot formulation that specifically encapsulates or entraps peptide therapeutics within a biodegradable matrix or carrier system to enable sustained in vivo release over an extended period, distinguishing it from other depot systems by its tailored design for the controlled delivery of peptide molecules susceptible to rapid degradation and clearance.
8
Publications
532
Citations
48
Authors
13
Institutions
Publications per year
2017–2026
3
8
Miriam Amiram, Kelli M. Luginbuhl, Xinghai Li et al. · Proceedings of the National Academy of Sciences · 2013 · 94 citations · Full text
1–5 of 8
48
2
h-index
2
h-index
2
h-index
2
h-index
1
h-index
1–5 of 48
13
Duke University
Durham, United States
2 h-index
17 publications
770 citations
MedinCell (France)
Jacou, France
2 h-index
5 publications
345 citations
Duke University Hospital
Durham, United States
2 h-index
4 publications
169 citations
Duke Medical Center
Durham, United States
2 h-index
5 publications
194 citations
University of Kentucky
Lexington, United States
1 h-index
6 publications
708 citations

Hospital Sant Joan de Déu Barcelona
Barcelona, Spain
1 h-index
2 publications
36 citations
Duke Cancer Institute
Durham, United States
1 h-index
1 publications
25 citations
Universitat de Barcelona
Barcelona, Spain
1 h-index
10 publications
180 citations
1–8 of 13
2 publications · 294 citations
3
h-index
PNAS · 1 publications · 94 citations
1
h-index
1 publications · 69 citations
1
h-index
1 publications · 25 citations
1
h-index
1 publications · 21 citations
1
h-index
1–5